- Design
- Retrospective multicentre cohort using a common data model (Korea, 2008–2024)
- Population
- 2,087 children and adolescents aged 3–18 starting methylphenidate
- Primary outcome
- Change in weight and weight centile within 3 months
- Effect
- −0.33 kg (95% CI −0.44 to −0.22); −2.49 centiles; ≥10-centile fall in 21.6% (28.6% preschool)
This retrospective study used a Korean common data model covering 17 hospitals from 2008 to 2024. It included 2,087 children and adolescents aged 3 to 18 who started methylphenidate and had weight recorded before and within 90 days after starting (69% male, 58% aged 6 to 10).
Within three months, mean weight fell by 0.33 kg (95% CI 0.22 to 0.44) and 2.49 centiles (2.15 to 2.83). Overall, 21.6% dropped 10 or more centiles, and in preschool children the figure was 28.6%.
In July 2025 the FDA warned of significant weight loss in young children taking stimulants for ADHD. This study gives a real-world size to that risk. The mechanism is appetite suppression, usually worst at midday, and it can be managed by dose timing, meal planning and monitoring.
- Weigh every child before starting methylphenidate and again within the first three months.
- Plot weight on a growth chart; a drop of 10 or more centiles warrants review of dose and diet.
- Take extra care in preschool children, who lost weight most often; methylphenidate is not licensed under 6 years in many countries.
- Encourage a good breakfast before the dose and an evening meal or snack when appetite returns.
- Continue monitoring height and weight at least every six months during treatment.
Why it matters
It turns a regulatory warning into a monitoring schedule a prescriber can follow.
Don't overread it
This is an uncontrolled retrospective study; it measures weight change, not long-term growth or health effects.
The statistics, in plain English
A mean loss of 0.33 kg sounds trivial, but averages hide the one in five who fell sharply. Children without follow-up weight data were excluded, which could bias the estimate in either direction. There was no comparison group of untreated children.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for clinical pharmacology, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free